Coexpression of fractalkine and its receptor in normal human endometrium and in endometrium from users of progestin-only contraception supports a role for fractalkine in leukocyte recruitment and endometrial remodeling

被引:80
作者
Hannan, NJ
Jones, RL
Critchley, HOD
Kovacs, GJ
Rogers, PAW
Affandi, B
Salamonsen, LA
机构
[1] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia
[2] Univ Edinburgh, Dept Reprod & Dev Sci, Edinburgh EH16 45B, Midlothian, Scotland
[3] Monash Univ, Dept Obstet & Gynecol, Clayton, Vic 3168, Australia
[4] Univ Indonesia, Dept Obstet & Gynecol, Fac Med, Jakarta 1033, Indonesia
关键词
D O I
10.1210/jc.2003-031379
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Leukocytes are critical mediators of endometrial remodeling, but the mechanisms by which leukocyte subpopulations enter the uterus are currently unknown. Endometrial leukocytes have no genomic progesterone receptors; thus, we hypothesized that leukocyte migration is induced indirectly by progesterone-regulated chemokines. Fractalkine (CX(3)CL1), a chemotactic membrane-bound adhesion factor, and its receptor (CX(3)CR1) were assessed by immunohistochemistry in endometrial samples across the menstrual cycle, in early pregnancy, and in women using progestin-only contraceptives. Fractalkine was localized predominantly to glandular epithelial and decidualized stromal cells, with the highest staining intensity in the secretory phase and early pregnancy. It was also detected in subpopulations of endometrial leukocytes (macrophages and uterine NK cells), with maximal numbers during the proliferative phase and early pregnancy. CX(3)CR1 was similarly colocalized to the glandular epithelium and decidualized stromal cells, with the highest expression in the secretory phase. CX(3)CR1-positive leukocytes (macrophages and neutrophils) were in greatest abundance during the menstrual phase. In the endometrium of women using progestin-only contraceptives, immunoreactive fractalkine was markedly reduced in the glandular epithelium, but was increased in decidualized stroma and infiltrating leukocytes. These findings support a number of roles for fractalkine in the endometrium, in the secretory phase, in early pregnancy, and when influenced by progestin-only contraceptives.
引用
收藏
页码:6119 / 6129
页数:11
相关论文
共 52 条
[31]   Fractalkine is expressed by smooth muscle cells in response to IFN-γ and TNF-α and is modulated by metalloproteinase activity [J].
Ludwig, A ;
Berkhout, T ;
Moores, K ;
Groot, P ;
Chapman, G .
JOURNAL OF IMMUNOLOGY, 2002, 168 (02) :604-612
[32]  
LUDWIG H, 1982, AM J OBSTET GYNECOL, V142, P796
[33]   Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users [J].
Marbaix, E ;
Vekemans, M ;
Galant, C ;
Rigot, V ;
Lemoine, P ;
Dubois, D ;
Picquet, C ;
Henriet, P ;
Twagirayezu, P ;
Sufi, S ;
Eeckhout, Y ;
Courtoy, PJ .
HUMAN REPRODUCTION, 2000, 15 :120-134
[34]   Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa [J].
Muehlhoefer, A ;
Saubermann, LJ ;
Gu, XB ;
Luedtke-Heckenkamp, K ;
Xavier, R ;
Blumberg, RS ;
Podolsky, DK ;
MacDermott, RP ;
Reinecker, HC .
JOURNAL OF IMMUNOLOGY, 2000, 164 (06) :3368-3376
[35]   DATING THE ENDOMETRIAL BIOPSY [J].
NOYES, RW ;
HERTIG, AT ;
ROCK, J .
FERTILITY AND STERILITY, 1950, 1 (01) :3-25
[36]  
Papadopoulos EJ, 2000, EUR J IMMUNOL, V30, P2355, DOI 10.1002/1521-4141(2000)30:8<2355::AID-IMMU2355>3.0.CO
[37]  
2-#
[38]   Cellular localization of fractalkine at sites of inflammation: antigen-presenting cells in psoriasis express high levels of fractalkine [J].
Raychaudhuri, SP ;
Jiang, WY ;
Farber, EM .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (06) :1105-1113
[39]   Chemokine ligand and receptor expression in the pregnant uterus - Reciprocal patterns in complementary cell subsets suggest functional roles [J].
Red-Horse, K ;
Drake, PM ;
Gunn, MD ;
Fisher, SJ .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (06) :2199-2213
[40]   A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection [J].
Robinson, LA ;
Nataraj, C ;
Thomas, DW ;
Howell, DN ;
Griffiths, R ;
Bautch, V ;
Patel, DD ;
Feng, LL ;
Coffman, TM .
JOURNAL OF IMMUNOLOGY, 2000, 165 (11) :6067-6072